We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Pathios Therapeutics and Sygnature Discovery Sign a Strategic and Innovative Partnership

Product News   Feb 15, 2019

 
Pathios Therapeutics and Sygnature Discovery Sign a Strategic and Innovative Partnership

Image credit: Sygnature Discovery

FURTHER INFORMATION
 
 
Advertisement
 

Related Product News

PerkinElmer Launches No-Wash Immunoassay for Neuroscience Disease and Therapeutics Research

Product News

PerkinElmer, Inc., today launched the life science industry’s first no-wash Ubiquitin phosphorylation at Serine 65 immunoassay that is aimed at helping scientists discover new therapeutic candidates earlier in the disease cycle.

READ MORE

PKamp™ Respiratory SARS-CoV-2 RT-PCR Panel Assay

Product News

PerkinElmer, Inc. (NYSE: PKI) announced today that its PKamp™ Respiratory SARS-CoV-2 RT-PCR Panel has received clearance to be marketed as an in vitro diagnostic (IVD) device in more than 30 countries.

READ MORE

CN Bio Announces Commercial Launch of Its Metabolism and Safety Toxicity Testing Services

Product News

CN Bio today announced the commercial launch of its Drug Metabolism and Safety Toxicity Testing Services. The new toxicity testing services also provide researchers with additional support and bandwidth during the COVID-19 pandemic, when laboratories are not at full capacity.

READ MORE

Like what you just read? You can find similar content on the communities below.

Biopharma Cancer Research Cell Science Diagnostics Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE